Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Transfusion Technologies Corp.

This article was originally published in The Gray Sheet

Executive Summary

Haemonetics' $15 mil. investment in the privately-held blood processing equipment maker adds up to a 19.8% ownership stake. Under the terms of a strategic relationship announced Nov. 8, Haemonetics will become the exclusive European and Asian distributor for Transfusion's OrthoPAT autotransfusion system for use in blood salvaging during orthopedic surgery. The funding will allow Transfusion "to develop and bring to market other new blood processing systems based on our patented Dynamic Disk technology," the firm says
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT012588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel